BRIEF-GSK says Shingrix phase 3 study met main goal
June 21, 2017 at 09:13 AM EDT
* Presents positive results from phase III revaccination study of its candidate shingles vaccine Shingrix at CDC's advisory meeting
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.